| abstract |
Provided is a novel compound that is useful as a medical drug in that said compound displays strong antimicrobial activity against gram-negative bacteria such as Pseudomonas aeruginosa and drug-resistant strains thereof, on the basis of LpxC-inhibiting activity. The novel compound is a hydroxamic acid derivative represented by general formula 1 (1) or a pharmaceutically acceptable salt thereof. |